Abstract
Multi-trait analysis has been shown to have greater statistical power than single-trait analysis. Most of the existing multi-trait analysis methods only work with a limited number of traits and usually prioritize high statistical power over identifying relevant traits, which heavily rely on domain knowledge. To handle diseases and traits with obscure etiology, we developed TraitScan, a powerful and fast algorithm that agnostically searches and tests a subset of traits from a moderate or large number of traits (e.g., dozens to thousands) based on either individual-level or summary-level genetic data. We evaluated TraitScan using extensive simulations and found that it outperformed existing methods in terms of both testing power and trait selection when sparsity was low or modest. We then applied it to search for traits associated with Ewing Sarcoma, a rare bone tumor with peak onset in adolescence, among 706 traits in UK Biobank. Our analysis revealed a few promising traits worthy of further investigation, highlighting the use of TraitScan for more effective multi-trait analysis as biobanks emerge. Our algorithm is implemented in an R package ‘TraitScan’ available at https://github.com/RuiCao34/TraitScan.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work is supported by the Children's Cancer Research Fund. Dr. Yang has also been funded by St Baldrick Career Award.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
The summary-level GWAS data for UK Biobank can be downloaded through instructions at https://pan.ukbb.broadinstitute.org/downloads. The algorithm for the proposed work is packaged in R, available at https://github.com/RuiCao34/TraitScan.
